why choose us

First received: November 23, 2023

Clinical Trial: A Phase 1, First-in-human Study of VX-828

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cystic Fibrosis

Study Type: INTERVENTIONAL


Official Title: A Phase 1, First-in-human Study of Safety, Tolerability, and Pharmacokinetics of VX-828

Brief Summary: The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 in healthy participants.

Read more